Please login to the form below

Not currently logged in
Email:
Password:

Manifesto puts patients first

A Healthcare Manifesto aimed at putting patients first has been published today by EuropaBio

A Healthcare Manifesto aimed at putting patients first has been published today by EuropaBio, the European Association for Bioindustries. In announcing its new policy priorities for 2009-2010, it outlines ways of promoting patient-centred healthcare systems.

The key policy areas involve: communicating the value of biotechnology innovation for healthcare systems; promoting Europe as the leading research hub for biotechnology and life sciences in the world; supporting the EU in delivering on its vision for access to orphan medicinal products for all patients affected by rare diseases; promoting reward for innovation, and sensitivity about, and understanding of, bio-ethical issues and values.

Biotechnology enables the development and manufacture of therapies for a number of rare and very rare diseases including genetic diseases, collectively affecting some 20 to 30 million Europeans and their families. Modern biotechnology leads to more targeted research that allows a better understanding of diseases, their causes and the identification of the best responders to new therapies.  

The chairman of EuropaBio's Healthcare Council, Andrea Rappagliosi, said: "EuropaBio's Healthcare Manifesto is our political road map for how to deliver a patient–centred approach to modern healthcare. This means putting patients first in Europe and working together with health authorities, payers and reimbursement agencies in order to ensure timely access to innovative therapies." 

"Our Healthcare Manifesto clarifies EuropaBio's policy goals and gives our Healthcare Council a strong position when working with policy makers," said Willy De Greef, secretary general of EuropaBio.

21st April 2009

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Anthill Agency

Digital communications agency empowering clients through their digital transformation journey. Whether through training, delivering solutions or devising digital strategies, we...

Latest intelligence

Where next in Alzheimer’s disease R&D?
How past failures and emerging biology are reshaping drug development...
Brain scan
Brain power: fresh approaches to Alzheimer’s drug discovery
New alliances are learning from past mistakes and breaking down research barriers...
Genomics integration: can the NHS rise to the challenge?
Experts gather to discuss the UK’s genomic landscape...

Infographics